What's new

Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation: 20/06/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation: 20/06/2022, Revision: 2, Status: Authorised

Feb 13, 2025 - 17:09
 0
Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation: 20/06/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation: 20/06/2022, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Docetaxel Accord, doce...

Next Article

B-52 Stratofortresses Begin Bomber Task Force 25-2 Deployment at RAF Fairford

Related Posts

Clinical Trials Information System

Clinical Trials Information System

Feb 24, 2025  0

Superseded - Rules of procedure of the Emergency Task F...

Apr 11, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 4 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 February 2025, 11:00 (CET) to 4 February 2025, 11:45 (CET)

Questions and answers clinic on Product Management Serv...

Feb 9, 2025  0